Cancer trials: Search results
Results: 149 items found. Showing page 1 of 6.
Refine results
Development of new primary prostate cancer cell lines
Trial short name: PCa Cell Growth
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Other
Two Stereotactic MRI-Guided Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer
Trial short name: 2SMART
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase:
5 Fractions of Pelvic SABR with Intra prostatic SABR Boost: A Phase II Study
Trial short name: 5STAR (PHART 14)
Cancer type: Genitourinary
Cancer location: Genitourinary
Disease stage: Early Cancer
Trial phase:
Capturing Canadian Real-World Data for AML Chemotherapy Ineligible Patients on Venetoclax
Trial short name: Abbvie LIVEN
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Other
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Acalabrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects ≤65 Years with Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma (ACE LY 312 Escalade)
Trial short name: ACE LY 312
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase: Phase 3
Phase 1b/3 global, randomized, controlled, open-label trial comparing treatment with RYZ101 to standard of care (SoC) therapy in subjects with inoperable, advanced, somatostatin receptor expressing (SSTR+), well-differentiated gastro-enteropancreatic neuroendocrine tumors (GEP-NETs) that have progressed following prior 177Lulabelled somatostatin analogue (177Lu-SSA) therapy
Trial short name: ACTION-1
Cancer type: Neuroendocrine
Cancer location: Neuroendocrine
Disease stage: Early Cancer
Trial phase: Phase 3
Men With Prostate Cancer on Active Surveillance - An Update of the Odette Cancer Centre Experience
Trial short name: Active Surveillance
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Other
Trial phase: Other
A Phase 3 Trial of Fianlimab (anti-LAG-3) and Cemiplimab versus Pembrolizumab in the Adjuvant Setting in Patients with Completely Resected High-risk Melanoma
Trial short name: ADJ LAG3
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo- and Active-Comparator Controlled Clinical study of Adjuvant V940 (mRNA-4157) Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With High-Risk Stage II-IV Melanoma
Trial short name: ADJ V94
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors
Trial short name: AGCT 1531
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
AGIOS A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of AG-881 in Subjects with Residual or Recurrent Grade 2 Glioma with an IDH1 or IDH2 Mutation
Trial short name: AGIOS
Cancer type: Central Nervous System
Cancer location: Brain
Disease stage: Early Cancer
Trial phase: Phase 3
Akeso Biopharma AK105-304/HAB35521 A Randomized, Double-blind, Multi-center Phase III Study of Penpulimab (AK105) Combined with Chemotherapy versus Placebo Combined with Chemotherapy as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma
Trial short name: AKESO
Cancer type: Head & Neck
Cancer location: Head & Neck
Disease stage: Early Cancer
Trial phase: Phase 3
An Internet-delivered Intervention for Re-adjustment to Sexual Intimacy with a Permanent Ostomy after Colorectal Cancer
Trial short name: An Internet-delivered Intervention for Re-adjustment to Sexual Intimacy with a Permanent Ostomy after Colorectal Cancer
Cancer type: Gastrointestinal
Cancer location: Colorectal
Disease stage: Early and Advanced Cancer
Trial phase: Other
Assessment of Quality of Life and Outcomes in Patients Treated with Stereotactic Body Radiotherapy (SBRT) for Primary Renal Cell Carcinoma (RCC): AQuOS-II
Trial short name: AQUOS II
Cancer type: Genitourinary
Cancer location: Kidney
Disease stage: Early Cancer
Trial phase:
PSMA MRI Guided prOstate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER
Trial short name: ARGOS/CLIMBER
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase:
A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
Trial short name: ARRY-134
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 1
: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent
Trial short name: ARTEMIDE-Biliary01
Cancer type: Gastrointestinal
Cancer location: Gastrointestinal
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase 1b Open-Label, Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-110 in Combination with Abiraterone in Patients with Metastatic Prostate Cancer
Trial short name: ARVINAS
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 1
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated With Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1
Trial short name: ASCENT-03
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician’s Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer, Whose Tumors Express PD-L1
Trial short name: ASCENT-04
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
Phase 1-2 Study of the Safety, Pharmacokinetics, and Preliminary Activity of ASTX660 in Subjects with Advanced Solid Tumors and Lymphomas
Trial short name: Astex 660
Cancer type: Blood Related
Cancer location: Lymphoma
Disease stage: Early and Advanced Cancer
Trial phase: Phase 2
A Phase 3, Randomized, Double-Blind, Placebo/Paclitaxel-Controlled Study of Batiraxcept (AVB-S6-500) in Combination With Paclitaxel in Patients With Platinum-Resistant Recurrent Ovarian Cancer (AXLerate-OC)
Trial short name: AVB500-OC-004
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase II/III Multicenter Study Evaluating The Efficacy And Safety of Multiple Targeted Therapies As Treatments for Patients With Advanced or Metastatis Non-Small Cell Cancer (NSCLC) Harboring ACtionable Somatic Mutations Detected in Blood (B-FAST: Blood-First Assay Screening Trial)
Trial short name: B-FAST
Cancer type: Lung
Cancer location: Lung
Disease stage: Advanced Cancer
Trial phase: Phase 2, Phase 3
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Trial short name: BASKET MEL
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 3
Men with Prostate Cancer on Active Surveillance -- An update of the Odette Cancer Centre Experience
Trial short name: Biobank
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Other
